Brett E Youngerman
Overview
Explore the profile of Brett E Youngerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jimenez A, Geist E, Connolly E, McKhann G, Youngerman B
J Neurosurg
. 2024 Nov;
:1-11.
PMID: 39612492
Objective: Several case series have investigated the use of laser interstitial thermal therapy (LITT) to treat cavernous malformations (CMs), for either seizure control or reduction of neurological symptoms and future...
2.
Delgardo M, Teasley D, Tang A, Izima C, Peet B, Pascual-Leone A, et al.
World Neurosurg
. 2024 Aug;
190:e931-e938.
PMID: 39147022
Background/objective: Intracranial epidermoid tumors (ETs) are rare, benign lesions that present significant challenges in neurosurgical management due to their propensity to encase vital neurovascular structures. We aimed to evaluate the...
3.
Spotnitz M, Ekanayake C, Ostropolets A, McKhann G, Choi H, Ottman R, et al.
JAMA Neurol
. 2024 Apr;
81(5):499-506.
PMID: 38557864
Importance: Interdisciplinary practice parameters recommend that patients with drug-resistant epilepsy (DRE) undergo comprehensive neurodiagnostic evaluation, including presurgical assessment. Reporting from specialized centers suggests long delays to referral and underuse of...
4.
Youngerman B, Banu M, Khan F, McKhann G, Schevon C, Jagid J, et al.
J Neurol Neurosurg Psychiatry
. 2023 Jun;
94(11):879-886.
PMID: 37336643
Background: Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) is a minimally invasive alternative to surgical resection for drug-resistant mesial temporal lobe epilepsy (mTLE). Reported rates of seizure freedom are variable...
5.
Simmons G, Gallitto M, Lee A, Baltuch G, Youngerman B, Wang T
Pract Radiat Oncol
. 2023 Jun;
13(5):e395-e399.
PMID: 37263538
Stereotactic radiosurgery (SRS) is a well-known modality for the treatment of malignant brain tumors. SRS, however, can also be used to treat non-malignant functional disorders such as epilepsy, tremor, trigeminal...
6.
Henderson F, Youngerman B, Niogi S, Alexander T, Tabaee A, Kacker A, et al.
J Neurosurg
. 2022 Dec;
138(5):1338-1346.
PMID: 36461840
Objective: The aim of this study was to determine if the distinction between planum sphenoidale (PS) and tuberculum sellae (TS) meningiomas is clinically meaningful and impacts the results of the...
7.
Castano V, Spotnitz M, Waldman G, Joiner E, Choi H, Ostropolets A, et al.
Epilepsia
. 2022 Sep;
63(11):2981-2993.
PMID: 36106377
Objective: More than one third of appropriately treated patients with epilepsy have continued seizures despite two or more medication trials, meeting criteria for drug-resistant epilepsy (DRE). Accurate and reliable identification...
8.
Najera R, Gregory S, Shofty B, Anand A, Gadot R, Youngerman B, et al.
J Neurosurg
. 2022 Jul;
138(2):347-357.
PMID: 35907186
Objective: Stereotactic radiosurgical capsulotomy (SRS-C) is an effective neurosurgical option for patients with treatment-resistant obsessive-compulsive disorder (TROCD). Unlike other procedures such as deep brain stimulation and radiofrequency ablation, the cost-effectiveness...
9.
Spielman D, Liebowitz A, Grewal M, Safi C, Overdevest J, Iloreta A, et al.
World J Otorhinolaryngol Head Neck Surg
. 2022 May;
8(1):66-72.
PMID: 35619935
Background: Historically sinonasal malignancies were always addressed via open craniofacial surgery for an oncologic resection. Increasingly esthesioneuroblastomas are excised using an exclusively endoscopic approach, however, the rarity of this disease...
10.
Terman S, Youngerman B, Choi H, Burke J
Epilepsia
. 2022 Mar;
63(6):1571-1579.
PMID: 35294775
Objective: This study was undertaken to characterize antiseizure medication (ASM) treatment pathways in Medicare beneficiaries with newly treated epilepsy. Methods: This was a retrospective cohort study using Medicare claims. Medicare...